NOVARTIS AG NAMENS-AKTIEN SF 0,5
NOVARTIS AG NAMENS-AKTIEN SF 0,5/ CH0012005267 /
904278
|
17/06/2024 10:54:37
|
Chg.
-1.120
|
Volume |
Bid10:54:37 |
Ask10:54:37 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
98.090EUR
|
-1.13%
|
-
Turnover: - |
98.090Bid Size: - |
98.400Ask Size: - |
223.44 bill.EUR |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
7.15 USD |
124.14% |
| EPS Diluted: |
- USD |
123.97% |
| Revenues per Share: |
20.49 USD |
-14.09% |
| Book Value per Share: |
20.49 USD |
-26.91% |
| Cash Flow per Share: |
6.35 USD |
227.31% |
| Dividend per Share: |
3.90 USD |
4.00% |
| Total |
in mill. |
|
| Revenues: |
46,660.00 USD |
-7.69% |
| Net Income: |
14,850.00 USD |
113.52% |
| Operating Cash Flow: |
14,458.00 USD |
- |
| Cash and Cash Equivalents: |
13,393.00 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
14.69 |
14.06 |
| P/S Ratio: |
5.13 |
4.91 |
| P/BV ratio: |
5.13 |
4.91 |
| P/CF Ratio: |
16.55 |
15.84 |
| PEG: |
0.12 |
0.11 |
| Earnings Yield: |
6.81% |
7.11% |
| Dividend Yield: |
3.71% |
3.88% |
| Market Capitalization |
|
| Market Capitalization: |
223.44 bill. EUR |
207.39 bill. EUR |
| Free Float Market Cap.: |
- EUR |
- EUR |
| Market Cap. / Employee: |
2.94 mill. EUR |
2.73 mill. EUR |
| Shares Outstanding: |
2.06 bill. |
|
Profitability
| Gross Profit Margin: |
73.27% |
| EBIT Margin: |
20.94% |
| Net Profit Margin: |
31.83% |
| Return on Equity: |
31.82% |
| Return on Assets: |
14.86% |
Financial Strength
| Liquidity I / Cash Ratio: |
50.75% |
| Liquidity II / Quick Ratio: |
77.68% |
| Liquidity III / Current Ratio: |
115.50% |
| Debt / Equity Ratio: |
114.17% |
| Dynam. Debt / Equity Ratio: |
368.50% |
Efficiency
| Employees: |
76,057 |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
613,487.25 USD |
| Net Income / Employee: |
195,248.30 USD |
| Total Assets / Employee: |
1,314,080.23 USD |
| * Fiscal Year End: |
31/12/2023 |
| Accounting Standard: |
IFRS |
